"MUST READ" Alright $IMMB Investors and Future Investors

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker

"MUST READ" Alright $IMMB Investors and Future Investors here is why I just posted a world of info on HIV/AIDS, To show everyone we are sitting on an ABSOLUTE LIFE CHANGER.

Amazing Website >> http://www.immunotechlab.com/


As you can see the market here is wide open for growth and by 2018 will consist of a $21 Billion Industry with a steady growth of 7% per annum. More IMPORTANTLY we are in an transition period where MANY current PATENTS will EXPIRE, leaving the door wide open for IMMB! 

Why is that important to IMMB, there is simply room for Competitors and definite interest for MERGERS/ACQUISITIONS of smaller cap companies. Something in this economy that is happening everyday.

Well here is my take as to WHY you should BUY IMMB.... 

IMMB currently carries a HV/AIDS PATENT valued at over $5 Million >> http://imagehost.vendio.com/a/8709739/view/Patent.png

So we are in the market. Now we need a game plan, well Dr. Harry Zhabilov worked his ass off for many years using his amazing scientific skills to create a patent... IMMB then realizes they can tap into a Billion Dollar Market with his Patents which for the record we have not one but 4 Patents. ...Mr.Zhabilov is an amazing Doctor....but he can't do it on his own so on October of 2012 he makes an even more Brilliant move than his Patent Creation, HE SIGNS a contract with Mr. Bo Linton and appointed him to be part of the Board of Directors .
Well for the people who don't know BO LINTON he has a habit of taking the companies he is involved with to the BIG BOARDS NYSE/NASDAQ)...His last one being MAGNEGAS whom just recently rang the closing bell!

As of February/2013 IMMB made another BIG move, they appointed Mr. Valentin Dimitrov to the board of directors of the company. Mr. Dimitrov is a CEO of M.T. Rose Corporation also Mr. Dimitrov is one of the owners of the second largest chemical plant in Bulgaria, Europe.

So now we have a growing Board with TOP notch Members whom carry HUGE connections.

Still with me, well on November 2012 a HUGE NEWS RELEASE Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Inc. Announces Breakthrough Results for HIV and AIDS Treatment for Terminal Salvage Patients

Followed by a much BIGGER News RELEASE JAN/2013 Link Provided >> http://www.otcmarkets.com/stock/IMMB/news
Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines 

Which in turn led to THE BIGGEST ONE TO DATE FEB/2013 Link Provided >> Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures

If you are still with me you are now adding everything up and saying to yourself HOLY SH*T, We are OFFICIALLY INVOLVED in THAT COVETED BILLION DOLLAR MARKET....and you should be saying IMMB is the MOST UNDERVALUED MEDICAL SCIENCE COMPANY in the OTC soon to be NASDAQ and or NYSE... 


From the last PR and in the words of MR.BO LINTON (read BOLD)>>
Mr. Linton further commented the company recently received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug". If confirmed the initial order would be in excess of several Million Dollars. This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company . In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.

Now that you are seeing what I am seeing I will show you the KICKER >> 

CURRENT SHARE STRUCTURE 
OUTSTANDING SHARES 60,500,000 give or take a handful
FLOAT 1 MILLION YES, MILLION (give or take a handful)CONFIRMED Jan.31/2013 in video interview with MR. LINTON (link provided ) >> http://www.otcmarkets.com/stock/IMMB/news
AUTHORIZED 150,000,000

Want More, I have more >>
INSIDERS HOLDINGS 98% of O/S Here is the PROOF >> 
Name of Shareholder Number of Shares
Harry Zhabilov 24,895,646 41.11
Ara Ghanime 24,895,646 41.11
Dow Jones Link 2,773,500 4.58
Allie Chang 600,000 1.0
Paul Felizian 600,000 1.0
Lord George Equities 5,400,000 9.0
Joseph Pittera 250,000 0.41
Harout Tovmasyan 151,000 0.25
Elie Sakayan 50,000 0.08
Hagop Parseghian 600,000 1.0
Others 339,896 0.46

So there you have it!

PS since last Wednesday in case you missed it we have seen LESS than 400,000 Shares TRADED or for the most part BOUGHT and we are up from .06 to .35 with MAJOR NEWS PENDING....with that said we have seen MAJOR BIDS UNTOUCHED where investors could have taken HUGE PERCENTAGE GAINS and SIMPLY REFUSED to knowing where IMMB is heading SHORT TERM and or LONG TERM! 

Good LUCK and REMEMBER only use this as a reference an never spend more than you are willing to lose.

Your Friend Cheeky!

PSS there is more to IMMB than HIV/AIDS Please go to WEBSITE and absorb as much as you can, They are diversified to say the least...link provided above!

Immunotech Laboratories Inc (IMMB) Stock Research Links

IMMB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Low GWP Refrigerants: Potential $13B Market by 2031

Updated Category News Views 2

Refrigerants: They're Hot in More Ways Than One Who would've thought refrigerants could be such a big deal? But here we are. The low global warming potential (GWP) refrigerants market is heating up, projected to jump from $8.17 billion in 2026 to a whopping $13.06 billion by 2031. That's a solid 9.8% CAGR if you're keeping score. The drivers? Well, we’ve got...

Continue Reading
LifeWave's Bold New Path in Human Performance

Updated Category News Views 4

Redefining the Everyday Athlete Not every day you see a wellness company talking about 'performance' in the broader human sense. Not just for the pros or those beating personal records but for anyone looking to lift the quality of their daily grind. That's the new line LifeWave's drawing in the sand with their spiffy 'Human Performance Technology.' They're looking to...

Continue Reading
Voter Power Flexes with Early Voting Celebrations

Updated Category News Views 9

Voter Engagement Hits a New High with Nationwide Parties Well, look at that—voter turnout's got its own party scene now, and it's making waves. As Vote Early Day approaches, the folks at When We All Vote are cranking up the volume on civic engagement with what's touted as the biggest Party at the Polls program yet. With almost 700 get-togethers riffing across the U.S.,...

Continue Reading
Auburn's Education Fair Bridges Students and Schools

Updated Category News Views 2

Bridging the Gap: Students Meet Future Employers Walking into Auburn University’s College of Education building, you'd get hit with the buzz of anticipation wafting through the halls. The Fall Education Interview Day was in full swing. With over 35 employers in attendance, this event wasn’t just any run-of-the-mill career fair. This was a chance for students to lock...

Continue Reading
Genedata's AI Push: A Biotech Game-Changer?

Updated Category News Views 12

A Glimpse into Genedata's Bold AI Integration So, here's a heck of an ambitious move in the biotech sphere with Genedata dropping the news about their integration of NVIDIA's BioNeMo AI models into their R&D workflows. These folks at Genedata are really riding the tech wave, offering up the new RFD4-Proteina release in what they call 'binder design' for biologics...

Continue Reading
TTM Technologies Faces Legal Scrutiny Amidst Stock Drop

Updated Category News Views 3

TTM Technologies: A Hard Hit and Legal Turmoil When the stock market throws a punch, not everyone sees it coming. Here we are with TTM Technologies (NASDAQ: TTMI) witnessing a sudden plunge that has left many investors scrambling. Just when the company seemed to have its sails set, the wind shifted direction, taking a chunk out of its market value as it reported its...

Continue Reading
Montega Kicks Off Agilyx Sponsored Equity Research

Updated Category News Views 2

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Continue Reading
Critical Questions to Ask When Buying Life Insurance

Updated Category News Views 1

Getting Under the Hood of Life Insurance Alright, so you're thinking about life insurance. Not exactly a day at the beach, but it’s one of those crucial life things to nail down. Paula Miller, a savvy insurance pro, walks through what to consider before you just slap down a signature and hope for the best. The Basics: Policy Types and Coverage Life insurance can be as...

Continue Reading
Travel FOMO Trumps High Costs: Family Drives Demand

Updated Category News Views 7

Sky-High Travel Costs? No Problem Who'd have thought folks would still be packing their bags with travel costs through the roof? Well, it seems like Americans have their priorities straight—or not, depending on how you look at it. Travel insurance provider Squaremouth reports insured trips are up 12.9% year over year, even with the average trip costing a whopping...

Continue Reading
Microtubule Defects Revealed: Impacts on Cancer Treatment

Updated Category News Views 5

Peering into the Heart of Microtubules Ever squint at a tapestry, only to find a rogue thread ruining the pattern? Well, that’s somewhat what scientists at Kanazawa University have found with microtubules, those tiny rods in our cells that usually keep it all together. Using some pretty fancy tech called high-speed atomic force microscopy, these folks peered into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Canada's Immigration Policy Change: Balancing Growth and Services

Updated Category News Views 198

Canada's Shift in Immigration Strategy In a significant policy announcement, the government of Canada has decided to cut back on immigration numbers. Prime Minister Justin Trudeau emphasized the need for this adjustment in response to the growing pressures on housing and social services, a situation exacerbated by the pandemic's aftermath. The Public's Changing...

Continue Reading
Ryder System's Impressive Q3 Results and Analyst Concerns

Updated Category News Views 58

Ryder System Reports Strong Q3 Earnings Ryder System Inc. (NYSE: R) has released its earnings report for the third quarter, showcasing a performance that surpassed analysts' expectations. The transportation and logistics firm reported adjusted earnings per share of $3.44, marginally exceeding the anticipated $3.41. While the revenue reached $3.2 billion, it slightly fell...

Continue Reading
Jericho Project Celebrates NYSE Milestone with New Housing

Updated Category News Views 274

Jericho Project Rings Closing Bell at NYSE in Celebration of Housing In a remarkable event at the New York Stock Exchange, Jericho Project celebrated the opening of Logan Fountain, a new supportive housing initiative that aims to help individuals and families experiencing homelessness. Tori Lyon, the organization's CEO, proudly rang the closing bell, marking a significant...

Continue Reading
RBC Warns of Pennon Group's Financial Challenges Ahead

Updated Category News Views 157

RBC Downgrades Pennon Group's Stock Outlook RBC Capital has recently revised its outlook on Pennon Group Plc (LSE:PNN) (OTC:PEGRF), downgrading the utility company's rating from Outperform to Sector Perform. The investment firm has also lowered its price target for the company's stock from GBP7.25 to GBP6.75. This decision stems from growing worries about the company's...

Continue Reading
RPM International's Impressive Margin Performance Fuels Optimism

Updated Category News Views 98

RPM International Sees Target Price Increase Amid Strong Earnings Recently, Seaport Global Securities reviewed its evaluation of RPM International (NYSE: RPM), boosting its stock price target from $140 to $150. This change comes after RPM's first-quarter earnings, which not only met but exceeded market expectations, highlighting the company's strength even in challenging...

Continue Reading